Discontinued — last reported Q2 '23
Robinhood Markets, Inc. Acquisitions decreased by 52.7% to $71.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 52.7%, from $150.00M to $71.00M. Over 3 years (FY 2021 to FY 2024), Acquisitions shows a downward trend with a -63.7% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31.25M | $31.25M | $31.25M | $0.00 | $0.00 | $0.00 | $0.00 | $23.25M | $23.25M | $23.25M | $23.25M | $0.00 | $6.00M | $0.00 | $0.00 | $150.00M | $71.00M |
| QoQ Change | — | +0.0% | +0.0% | -100.0% | — | — | — | — | +0.0% | +0.0% | +0.0% | -100.0% | — | -100.0% | — | — | -52.7% |
| YoY Change | — | — | — | — | -100.0% | -100.0% | -100.0% | — | — | — | — | -100.0% | -74.2% | -100.0% | -100.0% | — | -52.7% |